These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8387567)

  • 41. Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast Infection.
    Chiuppesi F; Wussow F; Johnson E; Bian C; Zhuo M; Rajakumar A; Barry PA; Britt WJ; Chakraborty R; Diamond DJ
    J Virol; 2015 Dec; 89(23):11884-98. PubMed ID: 26378171
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preclinical evaluation of an ALVAC (canarypox)--human cytomegalovirus glycoprotein B vaccine candidate.
    Gönczöl E; Berensci K; Pincus S; Endresz V; Méric C; Paoletti E; Plotkin SA
    Vaccine; 1995 Aug; 13(12):1080-5. PubMed ID: 7491815
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NKG2C(+)CD57(+) Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8(+) T Cell Evolution towards Senescence.
    Heath J; Newhook N; Comeau E; Gallant M; Fudge N; Grant M
    J Immunol Res; 2016; 2016():7470124. PubMed ID: 27314055
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Abortive human cytomegalovirus infection in patients after allogeneic bone marrow transplantation.
    de Gast GC; Boland GJ; Vlieger AM; de Weger RA; Verdonck LF; Zwaan FE; Jiwa NM
    Bone Marrow Transplant; 1992 Apr; 9(4):221-5. PubMed ID: 1318140
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Normalizing ELISPOT responses to T-cell counts: a novel approach for quantification of HCMV-specific CD4(+) and CD8(+) T-cell responses in kidney transplant recipients.
    Calarota SA; Chiesa A; Scaramuzzi L; Adzasehoun KM; Comolli G; Mangione F; Esposito P; Baldanti F
    J Clin Virol; 2014 Sep; 61(1):65-73. PubMed ID: 24961915
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular analysis of the immune response to human cytomegalovirus glycoprotein B (gB). II. Low gB-specific T and B cell responses are associated with expression of certain HLA-DR alleles.
    Curtsinger JM; Liu YN; Radeke R; Bryon MK; Fuad S; Bach FH; Gehrz RC
    J Gen Virol; 1994 Feb; 75 ( Pt 2)():301-7. PubMed ID: 8113751
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RT-qPCR-based microneutralization assay for human cytomegalovirus using fibroblasts and epithelial cells.
    Wang X; Peden K; Murata H
    Vaccine; 2015 Dec; 33(51):7254-7261. PubMed ID: 26552003
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety and immunogenicity of the Towne strain cytomegalovirus vaccine.
    Adler SP; Hempfling SH; Starr SE; Plotkin SA; Riddell S
    Pediatr Infect Dis J; 1998 Mar; 17(3):200-6. PubMed ID: 9535246
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Battle between Host Immune Cellular Responses and HCMV Immune Evasion.
    Manandhar T; Hò GT; Pump WC; Blasczyk R; Bade-Doeding C
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31344940
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses.
    Borysiewicz LK; Hickling JK; Graham S; Sinclair J; Cranage MP; Smith GL; Sissons JG
    J Exp Med; 1988 Sep; 168(3):919-31. PubMed ID: 2844952
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human cytomegalovirus (HCMV)-specific T cell but not neutralizing or IgG binding antibody responses to glycoprotein complexes gB, gHgLgO, and pUL128L correlate with protection against high HCMV viral load reactivation in solid-organ transplant recipients.
    Lilleri D; Zelini P; Fornara C; Zavaglio F; Rampino T; Perez L; Gabanti E; Gerna G
    J Med Virol; 2018 Oct; 90(10):1620-1628. PubMed ID: 29797330
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunoassay with cytomegalovirus early antigens from gene products p52 and CM2 (UL44 and UL57) detects active infection in patients with chronic fatigue syndrome.
    Beqaj SH; Lerner AM; Fitzgerald JT
    J Clin Pathol; 2008 May; 61(5):623-6. PubMed ID: 18037660
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunoaffinity purification of a 72K early antigen of human cytomegalovirus: analysis of humoral and cell-mediated immunity to the purified polypeptide.
    Rodgers B; Borysiewicz L; Mundin J; Graham S; Sissons P
    J Gen Virol; 1987 Sep; 68 ( Pt 9)():2371-8. PubMed ID: 2821176
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition.
    Jouand N; Bressollette-Bodin C; Gérard N; Giral M; Guérif P; Rodallec A; Oger R; Parrot T; Allard M; Cesbron-Gautier A; Gervois N; Charreau B
    PLoS Pathog; 2018 Apr; 14(4):e1007041. PubMed ID: 29709038
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum and cell-mediated viral-specific delayed cutaneous basophil reactions during cytomegalovirus infection of guinea pigs.
    Griffith BP; Askenase PW; Hsiung GD
    Cell Immunol; 1982 May; 69(1):138-49. PubMed ID: 6286148
    [No Abstract]   [Full Text] [Related]  

  • 56. Interleukin-4 is needed for the infection of monocytes by human cytomegalovirus.
    Kitajima H; Okubo Y; Honda J; Yonemitsu J; Yoshida N; Fumimori T; Oizumi K
    Intervirology; 2001; 44(4):264-70. PubMed ID: 11509890
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antigen-specific suppression of delayed type hypersensitivity to murine cytomegalovirus in MCMV-infected mice.
    Chong KT; Mims CA
    J Gen Virol; 1983 Nov; 64 (Pt 11)():2433-9. PubMed ID: 6315864
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.
    Wang Z; La Rosa C; Lacey SF; Maas R; Mekhoubad S; Britt WJ; Diamond DJ
    J Clin Virol; 2006 Mar; 35(3):324-31. PubMed ID: 16388983
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytomegalovirus vaccine. Specific humoral and cellular immune responses in human volunteers.
    Gehrz RC; Christianson WR; Linner KM; Groth KE; Balfour HH
    Arch Intern Med; 1980 Jul; 140(7):936-9. PubMed ID: 6247988
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytomegalovirus infection after orthotopic liver transplantation is restricted by a pre-existing antiviral immune response of the recipient.
    Bissinger AL; Oettle H; Jahn G; Neuhaus P; Sinzger C
    J Med Virol; 2004 May; 73(1):45-53. PubMed ID: 15042647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.